Drug Profile
Research programme: drug discovery - Astex/GlaxoSmithKline
Latest Information Update: 28 Jan 2022
Price :
$50
*
At a glance
- Originator Astex Therapeutics; GlaxoSmithKline
- Developer Astex Pharmaceuticals; GSK
- Class Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Unspecified
Most Recent Events
- 28 Jan 2022 No recent reports of development identified for preclinical development in Unspecified in United Kingdom
- 29 Jan 2020 Research programme: drug discovery -Astex pharmaceuticals/GlaxoSmithKline is still in preclinical development in Undefined in United Kingdom
- 28 Dec 2017 No recent reports of development identified for preclinical development in Undefined in United Kingdom